CVS Health names DeVaney

CVS Health appoints CVS Caremark president
Our drive to greater drug pricing transparency through innovation has never been more needed,” Ed DeVaney says.
CVS taps Ed DeVaney to head Caremark
The appointment marks the latest in a spate of leadership changes at CVS as the company’s insurance segment struggles to manage increased medical costs. David Joyner, who previously led Caremark, was named CVS president and CEO in October, replacing previous chief executive Karen Lynch.
CVS Health names Ed DeVaney president of PBM business
Ed DeVaney’s promotion is the latest leadership shakeup at CVS Health as the company works on a multi-year turnaround plan.
CVS taps Ed DeVaney to lead its Caremark PBM
CVS Health has named Ed DeVaney as president of its pharmacy benefit manager, CVS Caremark. | DeVaney has served as interim president of Caremark since December 2024. The president's role was vacated when David Joyner took over as CEO of CVS Health in October.
CVS names new chief executive for Caremark PBM division
In the latest executive shakeup at CVS, the pharmacy giant has named a new president of its pharmacy benefit management business.
CVS names longtime exec Ed DeVaney president of Caremark
DeVaney led CVS Caremark sales and account management as president, Employer & Health Plans. CVS Health. This story was originally published on Supermarketnews. CVS
CVS names PBM president
CVS Health has named Ed DeVaney as president of CVS Caremark. Mr. DeVaney was appointed interim president of the pharmacy benefit manager in December, according to a Feb. 17 news release from CVS Health. Mr. DeVaney joined CVS Health in 2005 and most recently served as president of employer and health plans for CVS Caremark.
CVS Health names DeVaney as President of CVS Caremark
CVS Health (CVS) named Ed DeVaney president of the company’s CVS Caremark pharmacy benefit management business. He was named interim president
'Health insurance companies are always going to need a PBM': CVS president Prem Shah
CVS is fighting to protect its PBM business as Trump and Congress look for ways to take out the pharmacy "middlemen."
Modern Healthcare2d
FTC's insulin case against UnitedHealth, CVS, Cigna PBMs advances
A federal judge denied a bid by CVS Health, Cigna and UnitedHealth Group to block the Federal Trade Commission's pricing case ...
CVS Stock Is Soaring. A Director Bets $2 Million on the Rally.
CVS director Mike Mahoney, whose day job is CEO of Boston Scientific, bought 30,000 shares of the healthcare company.
CVS’s stock is having its best day since 1999, after more than just earnings
CVS’s stock soared toward after its quarterly profit beat expectations by the widest margin in more than four years.